Biofrontera

Latest

Biofrontera: US market affected by crisis – annual sales increase

According to preliminary figures, after three quarters Biofrontera has a turnover between 20.8 million euros and 21.0 million euros. In…

Read More »
Latest

Biofrontera: Challenging market situation

Biofrontera increases sales in the first half of the year by 16 percent to 16.1 million euros. The operating result…

Read More »
Latest

Biofrontera: Doubts about the goals

Biofrontera has issued a convertible bond that brought 7.9 million euros into the cash register. With the fresh money you…

Read More »
Latest

Biofrontera share: Hype over? – Chart analysis

After the wild upward movement of the Biofrontera share from 2.705 euros to 5.67 euros within a few days, the…

Read More »
Latest

Biofrontera gets new money

Biofrontera plans to issue a mandatory convertible bond. The qualified subordinated paper is to run until December 20, 2021. The…

Read More »
Latest

Biofrontera: forecast is adjusted

In the second quarter, sales from product sales at Biofrontera fell by 52 percent to EUR 3.3 million. In the…

Read More »
Back to top button
Close
Close